In a rapidly evolving landscape, Jamaica, New Zealand and the Isle of Man are at the forefront of significant drug policy changes, shaping the future of cannabis and substance regulations.

The news comes on the heels of the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) reclassifying low-dose CBD products allowing registered pharmacists to supply approved low ...

VANCOUVER, British Columbia, July 18, 2019 (GLOBE NEWSWIRE) -- ICC International Cannabis Corp. (CSE: WRLD.U)(FWB: 8K51)(OTC: WLDCF) (the “Compa ...

To mark this milestone, Saffron Auckland CBD (or Platform 8 at 26 Te Taou Crescent will present its exquisite and extensive ...

The past several years have seen an enormous increase in cannabidiol (CBD) usage. The main reason for the increase may be from the numerous testimonials that CBD can be used to treat a vast array ...

The Christchurch office market has outperformed other major New Zealand centres in recent years, ... The new supply could push prime CBD office vacancy to between 7% and 10% during 2024-2025.

REPEAT - International Cannabis to Supply New Zealand’s NUBU Pharmaceuticals With Portfolio of Full-Spectrum Pharmaceutical THC/CBD Products Published Jul 18, 2019 8:00AM EDT ...